Key result
Omitting post-discharge anticoagulants is linked to ~60% higher 90-day mortality in medically ill patients.
Why the study?
Does antithrombotic use post-discharge reduce all-cause mortality within 90 days in acutely ill medical patients?
Cohort
Does antithrombotic use post-discharge reduce all-cause mortality within 90 days in acutely ill medical patients?
Post-discharge use of anticoagulants or antiplatelets is associated with a lower risk of 90-day mortality in acutely ill medical patients.
Answers are grounded in this paper and cite their sources.
Post-discharge antithrombotic omission was associated with higher mortality; hypothesis-generating and should not yet change practice.
Conflicting evidence exists regarding predictors of and antithrombotic benefit on mortality in hospitalised acutely-ill medical patients. We compared mortality risk within 90 days post-discharge among medically ill patients who did and did not receive antithrombotics. This retrospective claims analysis included patients ≥ 40 years with nonsurgical hospitalisation ≥ 2 days between 2005 and 2009 using the HealthCore Integrated Research Database. Antithrombotic use (i.e. anticoagulants and antiplatelets) post-discharge was captured from pharmacy claims. All-cause mortality was determined from Social Security Death Index; cause of death was identified from National Death Index database. Kaplan-Meier survival curves were generated and hazard ratios (HR) for mortality risk were estimated using Cox proportional hazards models. Patients prescribed anticoagulants or antiplatelets post-discharge had lower risk of short-term mortality. For the anticoagulant model, the most significant predictors of mortality were malignant/benign neoplasms (hazard ratio [HR] 1.6, 95% confidence interval [CI] 1.5-1.7), liver disease (HR 1.6, 95% CI 1.5-1.7), anticoagulant omission (HR 1.6, 95% CI 1.4-1.8), gastrointestinal or respiratory tract intubations (HR 1.5, 95% CI 1.3-1.7), and blood dyscrasias (HR 1.4, 95% CI 1.4-1.5). For the antiplatelet model, the most significant predictors of mortality were antiplatelet omission (HR 3.7, 95% CI 3.3-4.1), liver disease (HR 1.6, 95% CI 1.4-1.7), malignant/benign neoplasms (HR 1.6, 95% CI 1.5-1.6), gastrointestinal or respiratory tract intubations (HR 1.5, 95% CI 1.3-1.7), and blood dyscrasias (HR 1.4, 95% CI 1.4-1.5). These mortality risk factors may guide future studies assessing potential benefits of antithrombotics in specific subsets of patients.
No takes yet. Share an insight, caveat, or question.
Mahan et al. (2015) conducted a cohort in Acutely ill medical patients. Anticoagulant or antiplatelet omission vs. Anticoagulant or antiplatelet use was evaluated on All-cause mortality within 90 days post-discharge (HR 1.6, 95% CI 1.4-1.8). Omission of anticoagulants or antiplatelets post-discharge was associated with a higher risk of 90-day all-cause mortality in medically ill patients.
Synapse has enriched 10 related papers. Consider them for comparative context: